Stay updated on Sitagliptin in GVHD: Grade 3-4 Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD: Grade 3-4 Clinical Trial page.

Latest updates to the Sitagliptin in GVHD: Grade 3-4 Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2 on the page. This is a system update and does not modify study data.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedSite revision updated to v3.5.0. The previous revision v3.4.3 entry was removed.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.4.3 has been added to the record history and Revision: v3.4.2 has been removed.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.4.2 was added to the history, and the prior site-wide funding/operating status notice (v3.4.1) was removed. These are administrative updates and do not affect trial content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check79 days agoChange DetectedNotice added about a government funding lapse and NIH Clinical Center operating status, with a link for details. The page revision changed from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check86 days agoChange DetectedUI refinements were added to the history view, including a glossary toggle, color-coded change indicators and a revised revision label (v3.4.0), plus a capitalization tweak in the No FEAR Act data label.SummaryDifference1%

Stay in the know with updates to Sitagliptin in GVHD: Grade 3-4 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD: Grade 3-4 Clinical Trial page.